Department of Respiratory Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, China.
J Gene Med. 2010 Mar;12(3):276-86. doi: 10.1002/jgm.1435.
Beta-defensin-2 (BD-2) plays an important role in host defense against pathogenic microbe challenge by its direct antimicrobial activity and immunomodulatory functions. The present study aimed to determine whether genetic up-regulation of rat BD-2 (rBD-2) could ameliorate chronic Pseudomonas aeruginosa lung infection in rats.
Plasmid-encoding rBD-2 was delivered to lungs in vivo using linear polyethylenimine at 48 h before challenging with seaweed alginate beads containing P. aeruginosa. Macroscopic and histopathological changes of the lungs, bacterial loads, inflammatory infiltration, and the levels of cytokines/chemokines [interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, kertinocyte-derived chemokine (KC), macrophage inflammatory protein-2 (MIP-2)] were measured at 3 and 7 days post-infection (p.i.).
The overexpression of rBD-2 resulted in a significant increase in animal survival rate (at 3 days p.i.), a significant decrease in bacterial loads in the lungs (at 3 and 7 days p.i.), and significantly milder lung pathology. In addition, the overexpression of rBD-2 led to increased infiltration of polymorphonuclear neutrophils (PMN), and elevated protein expression of cytokines/chemokines (IL-1beta, TNF-alpha, KC and MIP-2) at the early stage of infection (at 3 days p.i.), at the same time as being dramatically decreased at the later stage of infection (at 7 days p.i.).
Genetic up-regulation of rBD-2 increased animal survival rate, and reduced bacterial loads in lungs after bacterial infection. The overexpression of rBD-2 also modulated the production of several cytokines/chemokines and increased PMN recruitment at the early stage of infection. Our findings indicate that the enhancement of BD-2 may be an efficacious intervention for chronic P. aeruginosa lung infection.
β-防御素-2(BD-2)通过其直接的抗菌活性和免疫调节功能,在宿主防御致病微生物挑战中发挥重要作用。本研究旨在确定大鼠 BD-2(rBD-2)的遗传上调是否可以改善大鼠慢性铜绿假单胞菌肺部感染。
在使用海藻酸钠珠粒挑战铜绿假单胞菌之前 48 小时,使用线性聚乙烯亚胺将编码 rBD-2 的质粒递送到肺部。在感染后 3 和 7 天(p.i.)测量肺部的宏观和组织病理学变化、细菌负荷、炎症浸润和细胞因子/趋化因子(IL-1β、TNF-α、角质细胞衍生的趋化因子(KC)、巨噬细胞炎症蛋白-2(MIP-2))的水平。
rBD-2 的过表达导致动物存活率显著增加(在 3 天 p.i.),肺部细菌负荷显著降低(在 3 和 7 天 p.i.),肺部病理学明显减轻。此外,rBD-2 的过表达导致多形核白细胞(PMN)浸润增加,并在感染早期(在 3 天 p.i.)上调细胞因子/趋化因子(IL-1β、TNF-α、KC 和 MIP-2)的蛋白表达,同时在感染后期(在 7 天 p.i.)急剧下降。
rBD-2 的遗传上调增加了动物在细菌感染后的存活率,并降低了肺部的细菌负荷。rBD-2 的过表达还调节了几种细胞因子/趋化因子的产生,并在感染早期增加了 PMN 的募集。我们的研究结果表明,增强 BD-2 可能是治疗慢性铜绿假单胞菌肺部感染的有效干预措施。